Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$0.62 - $3.6 $10,388 - $60,318
-16,755 Closed
0 $0
Q1 2019

Feb 14, 2022

BUY
$2.2 - $3.6 $36,861 - $60,318
16,755 New
16,755 $2,000

Others Institutions Holding NAVB

About NAVIDEA BIOPHARMACEUTICALS, INC.


  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Brr Op Co, LLC Portfolio

Follow Brr Op Co, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brr Op Co, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brr Op Co, LLC with notifications on news.